Engineering CAR T cells for enhanced efficacy and safety
Despite its success in treating hematologic malignancies, chimeric antigen receptor (CAR) T cell therapy faces two major challenges which hinder its broader applications: the limited effectiveness against solid tumors and the nonspecific toxicities. To address these concerns, researchers have used s...
Main Authors: | Yiqian Wu, Ziliang Huang, Reed Harrison, Longwei Liu, Linshan Zhu, Yinglin Situ, Yingxiao Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
AIP Publishing LLC
2022-03-01
|
Series: | APL Bioengineering |
Online Access: | http://dx.doi.org/10.1063/5.0073746 |
Similar Items
-
Engineering inducible biomolecular assemblies for genome imaging and manipulation in living cells
by: Qin Peng, et al.
Published: (2022-12-01) -
Ultrasound Control of Genomic Regulatory Toolboxes for Cancer Immunotherapy
by: Yiqian Wu, et al.
Published: (2024-12-01) -
Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies
by: Marcos de Lima, et al.
Published: (2024-08-01) -
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma
by: Gils Roex, et al.
Published: (2020-12-01) -
Integration of FRET and sequencing to engineer kinase biosensors from mammalian cell libraries
by: Longwei Liu, et al.
Published: (2021-08-01)